| Normalized noise energy as an acoustic measure to evaluate pathologic voice H Kasuya, S Ogawa, K Mashima, S Ebihara The Journal of the Acoustical Society of America 80 (5), 1329-1334, 1986 | 367 | 1986 |
| Knowledge, attitudes and practices regarding HIV/AIDS among male high school students in Lao People's Democratic Republic B Thanavanh, M Harun‐Or‐Rashid, H Kasuya, J Sakamoto African Journal of Reproduction and Gynaecological Endoscopy 16 (1), 2013 | 223 | 2013 |
| A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer A Nakao, H Kasuya, TT Sahin, N Nomura, A Kanzaki, M Misawa, T Shirota, ... Cancer gene therapy 18 (3), 167-175, 2011 | 167 | 2011 |
| The current status and future prospects of oncolytic viruses in clinical trials against melanoma, glioma, pancreatic, and breast cancers IR Eissa, I Bustos-Villalobos, T Ichinose, S Matsumura, Y Naoe, ... Cancers 10 (10), 356, 2018 | 162 | 2018 |
| Acoustic analysis of pathological voice: some results of clinical application M Hirano, S Hibi, T Yoshida, Y Hirade, H Kasuya, Y Kikuchi Acta oto-laryngologica 105 (5-6), 432-438, 1988 | 146 | 1988 |
| Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma S Nomoto, T Kinoshita, K Kato, S Otani, H Kasuya, S Takeda, N Kanazumi, ... British journal of cancer 97 (9), 1260-1265, 2007 | 144 | 2007 |
| A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer Y Hirooka, H Kasuya, T Ishikawa, H Kawashima, E Ohno, IB Villalobos, ... BMC cancer 18, 1-9, 2018 | 138 | 2018 |
| Constructing a spoken dialogue corpus for studying paralinguistic information in expressive conversation and analyzing its statistical/acoustic characteristics H Mori, T Satake, M Nakamura, H Kasuya Speech Communication 53 (1), 36-50, 2011 | 115 | 2011 |
| An acoustic analysis of pathological voice and its application to the evaluation of laryngeal pathology H Kasuya, S Ogawa, Y Kikuchi, S Ebihara Speech communication 5 (2), 171-181, 1986 | 115 | 1986 |
| The potential of oncolytic virus therapy for pancreatic cancer H Kasuya, S Takeda, S Nomoto, A Nakao Cancer Gene Therapy 12 (9), 725-736, 2005 | 108 | 2005 |
| Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene TM Pawlik, H Nakamura, JT Mullen, H Kasuya, SS Yoon, ... Cancer 95 (5), 1171-1181, 2002 | 101 | 2002 |
| Genomic signature of the natural oncolytic herpes simplex virus HF10 and its therapeutic role in preclinical and clinical trials IR Eissa, Y Naoe, I Bustos-Villalobos, T Ichinose, M Tanaka, W Zhiwen, ... Frontiers in oncology 7, 149, 2017 | 87 | 2017 |
| Regulation of herpes simplex virus γ134.5 expression and oncolysis of diffuse liver metastases by Myb34.5 H Nakamura, H Kasuya, JT Mullen, SS Yoon, TM Pawlik, ... The Journal of clinical investigation 109 (7), 871-882, 2002 | 81 | 2002 |
| Simultaneous estimation of vocal tract and voice source parameters based on an ARX model W Ding, H Kasuya, S Adachi IEICE transactions on information and systems 78 (6), 738-743, 1995 | 81 | 1995 |
| Acoustic nature of the whisper M Matsuda, H Kasuya Sixth European Conference on Speech Communication and Technology, 1999 | 69 | 1999 |
| Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer H Kasuya, Y Nishiyama, S Nomoto, J Hosono, S Takeda, A Nakao Journal of surgical oncology 72 (3), 136-141, 1999 | 66 | 1999 |
| Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer TT Sahin, H Kasuya, N Nomura, T Shikano, K Yamamura, T Gewen, ... Cancer gene therapy 19 (4), 229-237, 2012 | 65 | 2012 |
| Regulation of herpes simplex virus 1 replication using tumor-associated promoters JT Mullen, H Kasuya, SS Yoon, NM Carroll, TM Pawlik, S Chandrasekhar, ... Annals of surgery 236 (4), 502-513, 2002 | 63 | 2002 |
| Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis S Yamada, S Takeda, T Fujii, S Nomoto, N Kanazumi, H Sugimoto, ... Annals of surgery 246 (2), 254-258, 2007 | 61 | 2007 |
| Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy H Kasuya, Y Nishiyama, S Nomoto, F Goshima, S Takeda, I Watanabe, ... Cancer gene therapy 14 (6), 533-542, 2007 | 59 | 2007 |
Kathleen RastleRoyal Holloway University of London在 rhul.ac.uk 的电子邮件经过验证
Kathleen RastleRoyal Holloway University of London在 rhul.ac.uk 的电子邮件经过验证